AquaVac PD3 emulsion for injection for Atlantic salmon
AquaVac PD3 emulsion for injection for Atlantic salmon
Authorised
- Aeromonas salmonicida, subsp. salmonicida, Inactivated
- Salmon pancreas disease virus, strain F93-125, Inactivated
- Infectious pancreatic necrosis virus, Inactivated
Product identification
Medicine name:
AquaVac PD3 emulsion for injection for Atlantic salmon
AquaVac PD3 emulsion for injection for Atlantic salmon
Active substance:
- Aeromonas salmonicida, subsp. salmonicida, Inactivated
- Salmon pancreas disease virus, strain F93-125, Inactivated
- Infectious pancreatic necrosis virus, Inactivated
Target species:
-
Atlantic salmon
Route of administration:
-
Intraperitoneal use
Product details
Active substance and strength:
-
Aeromonas salmonicida, subsp. salmonicida, Inactivated80.00Relative Percentage Survival1.00Dose
-
Salmon pancreas disease virus, strain F93-125, Inactivated
-
Infectious pancreatic necrosis virus, Inactivated1.50enzyme-linked immunosorbent assay unit1.00Dose
Pharmaceutical form:
-
Emulsion for injection
Withdrawal period by route of administration:
-
Intraperitoneal use
-
Atlantic salmon
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI10AL
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- Bottles of polyethylene terephthalate (PET) closed with a rubber stopper and aluminium cap.Package size: 500 ml (5,000 doses).
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10996/274/001
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0339/001
Concerned member states:
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: